Program subject to change - check the app for the most current updates.
7:30am - 5:00pm South Convention Lobby Registration Open
 8:00am - 4:30pm Tower Court A I. Denver Vitiligo Global Issues Consensus Conference (VGICC) 

Outcome Instruments and Future Directions in Clinical/Translational Research.

8:00 - 9:30 Imaging/Photography

Chairs: Alain Taïeb, Richard Spritz

  • Introduction (Chairs)
  • Abstracts discussed (10 mn presentation):
  • Total body UV imaging with UV flash coupled Fotofinder ATBM : First Experience in the Vitiligo Clinic
    Alain Taïeb, Nanja Van Geel , Julien Seneschal, Mauro Picardo, Bruno Capdepon, Nicolas Andreu, Tobias Fuchs. Depts of Dermatology, Bordeaux, France and  Ghent, Belgium, San Gallicano Institute, Rome, Italy, FotoFinder Systems GmbH, Bad Birnbach, Germany
  • A Pilot Study to Determine Vitiligo Severity Using Computer Image Analysis
    Steven Thng et al (Singapore)
  • Validation of a mobile app for automatic measurement of vitiligo affected target regions (Sanne Uitentuis …)
    Albert Wolkerstorfer, Amsterdam, the Netherlands
  • Validation of ImageJ software for digital measurement of target lesions in vitiligo
    Nanja Van Geel  et al (Ghent)

Coffee break

10:00-12:00 Other Outcome Measures  
Chairs: Nanja van Geel, Amit Pandya

  • Physician and patient-reported (discussion of the Rome VGICC and Detroit workshops)
  • Introduction (Chairs)
  • Discussion of VES  VES+
    Nanja, Amit
  • Abstracts discussed (10 mn presentation):
  • VItiligo Cosmetic Acceptability Scale (VICAS): preliminary results on the validity and reliability of a new measurement tool in vitiligo
    Lommerts et al, Amsterdam
  • Development and Validation of the Vitiligo Extent Score for Target Areas (VESTA): an International Collaborative Study
    Jung-Min Bae, Suwon, Korea
  • International INitiative for Outcomes (INFO) for vitiligo-results of workshop with patients and progress so far
    Viktoria Eleftheriadou, Nottingham, UK

Lunch break

1:00-2:30 Phototherapy
Chairs: Iltefat Hamzavi, Ichiro Katayama

  • Discussion of US phototherapy recommendations 
  • Introduction (Chairs)
  • Abstracts discussed (10 mn presentation):
  • Identifying Gaps in the Narrowband Ultraviolet B Phototherapy Guidelines for Vitiligo
    Bhatia, Bhavnit K. Detroit, USA
  • First randomized controlled trial comparing UVB versus UVB+topical corticosteroids
    Albert Wolkerstorfer et al (Amsterdam, The Netherlands)
  • Atorvastatin + UVB versus UVB alone in progressive vitiligo
    Thierry Passeron (Nice, France) and Steven Thng (Singapore)

Coffee break

3:00-4:30 From Basic Science to Translational Medicine
Chairs: J Harris, M Picardo

  • Multicenter collaborations, development of a universal large-scale enrollment protocol, clinical trials, general discussion of future directions (Pharma interaction-personalized medicine)
  • Introduction (Chairs)
  • Abstract discussed (10 mn presentation):
  • MicroRNA-211 regulates oxidative phosphorylation and energy metabolism in human vitiligo
    Sahoo et al (Orlando, USA)
  • General Discussion/Perspectives/Roadmap
8:00am - 4:30pm Tower Court B II. Giant Congenital Nevi (GCN)

Morning Session
Chairs: Harper Price, Mark Beckwith

  • 9:00-9:30 Registration
  • 9:30-09:50 International registry of GCMN and ongoing collaborative research
    Speaker: Dr Josep Malvehy, Barcelona, Spain
  • 9:50-10:10 Psychological support initiatives for CMN
    Speaker: Prof Pierre Vabres, Dijon, France
  • 10:10-10:30 Changing the image of CMN
    Speaker: Mrs Jodi Whitehouse, Liverpool, UK
  • 10:30-11:00 Coffee
  • 11:00-11:20 Murine models of pigmentary disorders
    Speaker: Dr Lionel Larue, Paris, France
  • 11:20-11:40 Zebrafish models of pigmentary disorders
    Speaker: Dr Elizabeth Patton, Edinburgh, UK
  • 11:40-12:00 Phenotypic and genotypic factors governing the natural history of CMN lightening, and implications for treatment
    Speaker: Dr Satyamaanasa Polubothu, London, UK
  • 12:00-12:20 Vision for an International CMN Initiative
    Speaker: Veronica Kinsler, London, UK

12:20-1:00 Lunch

Afternoon Session
Chairs: Harper Price, Josep Malvehy, Veronica Kinsler

  • 1:00-2:30 Brainstorming session for international collaboration and/or concensus statements
8:00am - 4:30pm Tower Court C III. Challenging Pigmentary Disorders and Skin of Color

  • 9:00-9:15 Introduction & Welcome - Seemal R. Desai MD
  • Overview of Skin of Color Society
  • 9:15-9:40 Management of Hair Disorders in Skin of Color - an update
    Amy McMichael MD
  • 9:40-10:05 Phototherapy update for Vitiligo
    Amit Pandya MD
  • 10:05-10:30 Recent updates in the pathogenesis of Vitiligo
    John Harris MD
  • 10:30-10:55 Pathogenesis of Melasma - An Update
    Pearl Grimes MD
  • 10:55-11:20 Clinical Challenges in Skin of Color
    Nada Elbuluk MD
  • 11:20-11:45 Surgical Therapy for Pigmentary Disorders
    Iltefat Hamzavi MD
  • 11:45-12:10 Psoriasis in Skin of Color
    Seemal Desai MD
  • 12:10-12:30 Question & Answer Panel Discussion
8:00am - 4:30pm Tower Court D IV. Melanin Chemistry and Biophysics

  • 9:30 - 9:35 Introduction & Welcome
    Chairs:Shosuke Ito, Alessandra Napolitano, Kazumasa Wakamatsu
  • 9:35-9:55 Bioorganic chemistry of eumelanin
    Jason M. Belitsky (Oberlin College, USA)
  • 9:55-10:15 Reactions of dopaminequinone analogues: a density functional theory based study
    Ryo Kishida (Osaka University, Japan
  • 10:15-10:35 Melanin structure research; quantum chemical study and experimental results of 5, 6-dihydroxyindole oligomer as eumelanin model molecules
    Kenzou Koike (KAO Corp., Japan)
  • 10:35-10:55 Photobleaching of a synthetic pheomelanin increases its photosensitizing ability
    Tadeusz Sarna (Jagiellonian University, Poland)

10:55-11:10 Coffee Break and Free Discussion

  • 11:10-11:30 In search of a comprehensive model for insect cuticular pigmentation
    Hanine Barek (University of Massachusetts, USA)
  • 11:30-11:50 Critical role of quinone methides in catecholamine metabolism
    Manickam Sugumaran (University of Massachusetts, USA)
  • 11:50-12:10 Structure and synthesis of neuromelanins and their synthetic analogues
    Luigi Zecca (IBT, CNR, Italy)

12:10-1:00 Lunch Time

Chair: Lugi Zecca, Tardeus Sarna, Manickam Sugumaran

  • Melanin from 5,6-dihydroxyindole-2-carboxylic acid methyl ester with a potential for dermo-cosmetic applications.
    Alessadra Napolitano (University of Naples, Italy)
  • 1:20-1:40 A preliminary screening of mushroom tyrosinase inhibition properties of natural and bioinspired phenolic compounds
    Lucia Panzella (University of Naples, Italy)
  • 1:40-2:00 Human tyrosinase is mandatory for screening of effective inhibitors of melanin production – Mushroom tyrosinase is misleading
    Ludger Kolbe (Beiersdorf AG, Germany)
  • 2:00-2:20 The Pro-oxidant activity of rhododendrol-eumelanin (oligomer) is enhanced by UVA irradiation
    Shosuke Ito (Fujita Health University, Japan)

2:20-2:35 Coffee Break and Free Discussion

  • 2:35-2:55 Roles of pH in mixed melanogenesis
    Kazumasa Wakamatsu (Fujita Health University, Japan)
  • 2:55-3:15 Regulation of melanosome pH by soluble adenylyl cyclase determines skin and hair pigmentation
    Jonathan H. Zippin/Dalee Zhou (Weill Cornell Medical College, USA
  • 3:15-3:35 Electrochemical reverse engineering to probe redox activities
    Gregory F. Payne (University of Maryland, USA)
  • 3:35-3:40 Closing Remarks
    Chairs: Lugi Zecca, Tardeus Sarna, Manickam Sugumaran

Each presentation time is 20 min including 3 min's discussion time

The refreshment break and lunch are partly supported by Kao Biological Science Laboratories 

9:30am - 10:00am Tower Court Foyer COFFEE BREAK
12:00pm - 1:30pm Tower Court Foyer LUNCH BREAK
3:00pm - 3:30pm Tower Court Foyer COFFEE BREAK
5:00pm - 6:00pm Tower Court A ASPCR Regional Societies Council Meeting
5:00pm - 6:00pm Tower Court B JSPCR Regional Societies Council Meeting
5:00pm - 6:00pm Tower Court C PASPCR Regional Societies Council Meeting
6:00pm - 8:00pm Tower Court D IFPCS 1st Council Meeting
8:00pm - 10:00pm Offsite IFPCS Council Dinner